Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Cardiac hypertrophy in rats after intravenous administration of CI-959, a novel antiinflammatory compound: morphologic features and pharmacokinetic and pharmacodynamic mechanisms. [electronic resource] by
- Low, J E
- Metz, A L
- Mertz, T E
- Henry, S P
- Knowlton, P
- Loewen, G
- Sommers, C S
- Robertson, D G
- Olszewski, B J
- Schroeder, R L
Producer: 19951107
In:
Journal of cardiovascular pharmacology vol. 25
Availability: No items available.
|
|
6.
|
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology. [electronic resource] by
- Ryan, M J
- Bjork, F A
- Cohen, D M
- Coughenour, L L
- Major, T C
- Mathias, N P
- Mertz, T E
- Olszewski, B J
- Singer, R M
- Evans, D B
Producer: 19860917
In:
The Journal of pharmacology and experimental therapeutics vol. 238
Availability: No items available.
|
|
7.
|
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor. [electronic resource] by
- Ryan, M J
- Boucher, D M
- Cohen, D M
- Essenburg, A D
- Major, T C
- Mertz, T E
- Olszewski, B J
- Randolph, A E
- Singer, R M
- Kaplan, H R
Producer: 19840320
In:
The Journal of pharmacology and experimental therapeutics vol. 228
Availability: No items available.
|